Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
fda
alzheimer's disease
biogen
cancer
eisai
eli lilly
pfizer
abbvie
boehringer ingelheim
bristol-myers squibb
cancer immunotherapy
celgene
What
bio
5
×
roundup
week
5
×
alzheimer’s
biogen
companies
drug
ipo
life
moves
science
aducanumab
america
amyloid
angst
annual
arena’s
assessed
attention
bagged
billions
biogen’s
biotech
black
bounty
brammer
cig
comeback
communities
conference
continue
continues
convoluted
corner
deals
debut
delivered
democrats
diamond
diamond’s
Language
unset
Current search:
week
×
bio
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
